HSV-2
1
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AiCurisAIC316
AiCurisAIC316
Clinical Trials (2)
Total enrollment: 247 patients across 2 trials
Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes
Start: Oct 2012Est. completion: Jul 201391 patients
Phase 2Terminated
Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2
Start: Mar 2010Est. completion: Mar 2011156 patients
Phase 2Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.